Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

882.546
+3.7570.43%
Number of Gainers:9
Number of Losers:8
Number of Flat:- -
PE:- -
High:882.827
Open:876.263
Low:869.207
Close:878.789
Volume:67.05M
Turnover:553.58M
Market Cap:596.46B
Float Cap:494.01B

Loading ...

CSPC Pharmaceutical - Goserelin Sustained-Release Injection (Syh9102 Injection) Obtains Clinical Trial Approval in China

THOMSON REUTERS
·
Sep 09

Fosun Pharma Spends HK$2.63 Million Buying Back Shares on September 9

Stock News
·
Sep 09

Alibaba Health Information Technology Stock Slips 2.9% in Hong Kong

Dow Jones
·
Sep 09

Sinopharm Group Stock Slips 2.1% in Hong Kong

Dow Jones
·
Sep 09

BYD Electronic (International) Stock Sheds 2.4% in Hong Kong

Dow Jones
·
Sep 09

Sino Biopharmaceutical Stock Slides 4.0% in Hong Kong, Underperforms Competitors

Dow Jones
·
Sep 09

JD Health International Stock Sheds 3.7% in Hong Kong

Dow Jones
·
Sep 09

AH Share Premium Rankings as of September 9 Trading Close

Stock News
·
Sep 09

UBS: Mixed First-Half Results for Chinese Pharma Stocks, Names Simcere as Top Pick

Stock News
·
Sep 09

Dizal Pharmaceutical's Birelentinib Shows Promise in Lymphoma Study Published in Blood Cancer Journal

Stock News
·
Sep 09

BOC International sees pharma sector earnings recovery as industry enters a reversal cycle

Stock News
·
Sep 09

Ascletis Hits 4-Week High on Initiating US Phase I Study on Obesity Drug

Reuters
·
Sep 09

TYK Medicines-B Chairman, President and CEO Wu Yusheng Plans Share Purchase

Stock News
·
Sep 08

Harvest Machinery Accelerates Autumn Grain Collection in Garzê, Sichuan

Deep News
·
Sep 08

Genfleet-B Completes Share Buyback Worth HK$1.54 Million

Stock News
·
Sep 08

ALEBUND-B Wins US FDA Nod to Start Trial of Novel IgA Nephropathy Drug AP308

Stock News
·
Sep 08

CSPC Pharmaceutical Gets China Approval for Eye Drug Clinical Trials

MT Newswires Live
·
Sep 08

ASC36 Obesity Therapy Enters Phase I Trials in the US by Ascletis

Stock News
·
Sep 08

Ascletis Pharma - Initiates U.S. Phase I Study for Asc36 Oral Tablets for Obesity

THOMSON REUTERS
·
Sep 08

SBP Group Unveils Preclinical Findings for Oral STAT6 Degrader TQH5528 at ERS 2026

Stock News
·
Sep 08